Abstract
to tetracycline, co-trimoxazole and erythromycin were variable during the study period. Conclusion: The number of isolates reported through the Network was different from those published by the annual summaries of cholera cases in WHO Weekly Epidemiological Record. These discrepancies reflect the limitations in surveillance and reporting systems. Data demonstrate that choleare is present in the Americas Region with potential for oubreaks. Laboratory surveillance should be integrated in the national surveillance systems for accurate information on outbreaks and burden of disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
